Palantir Technologies reported fourth-quarter revenue of $635 million, up 44% year-over-year, and delivered adjusted operating income of $102 million, comfortably ahead of the average Wall Street estimate for $580 million in sales. Teradyne posted Q4 bookings of $1.15 billion, a 37% increase from the prior year, driven by strong demand for automated test equipment used in the manufacture of AI accelerators. Both companies cited Nvidia’s GPUs and AI platforms as key inputs to their own product pipelines. Investors view these outperformance indicators—Palantir’s 5x growth in large customer deals and Teradyne’s 28% sequential rise in data-center test orders—as positive leading signals for Nvidia’s data-center division ahead of its Feb. 25 earnings report.

In a televised interview, Nvidia CEO Jensen Huang emphasized that there is 'no drama' with OpenAI, reaffirming that Nvidia’s September investment framework remains 'on track.' According to people familiar with the negotiations, Nvidia is now finalizing terms to invest approximately $20 billion in OpenAI’s latest funding round, representing one-fifth of the total targeted raise. Huang also confirmed Nvidia would consider participating in any eventual OpenAI IPO. This clarification follows reports that the original $100 billion agreement had stalled; Huang’s comments helped stem a 3.4% slide in Nvidia’s share price on the day of the interview.

Despite announcing a landmark $100 billion collaboration with OpenAI last September, neither party has executed definitive contracts or exchanged funds. The Wall Street Journal reported that talks are 'on ice' due to Nvidia internal concerns over OpenAI’s monetization strategy. Nevertheless, OpenAI’s projected demand for hundreds of thousands of Nvidia H100 and future Blackwell-series GPUs underpins its growth model, while Nvidia relies on OpenAI’s high-profile services to drive enterprise adoption of its DGX systems. Nvidia’s market capitalization, which peaked above $5 trillion in October, still reflects investor confidence in this symbiotic relationship even as each side evaluates alternative chip and investment partners.